Daraprim is an extremely important drug for the treatment of parasitic infections in AIDS patients. Martin Shrekli, founder of Turing Pharmaceuticals, has recently increased the price of the drug, which has long been set at an extremely affordable rate, to an absurdly high price. This is not a product that can be boycotted or otherwise protested as it is necessary for the lives of the patients. His actions, while not necessarily criminal, are extremely morally wrong and will lead to damage to the economic status of lower and middle class families.
This is historical material “frozen in time”. The website is no longer updated and links to external websites and some internal pages may not work.
